This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by González-Zuloeta Ladd, A. M. Articles by van Duijn, C. Search for Related Content PubMed PubMed Citation Articles by González-Zuloeta Ladd, A. M. Articles by van Duijn, C.

Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Breast Cancer Risk

Epidemiology and Biostatistics Department, Erasmus Medical Center, Rotterdam, the Netherlands

Requests for reprints: Cornelia van Duijn, Department of Epidemiology and Biostatistics, Erasmus Medical Center, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands. Phone: 31-10-408-7394; Fax: 31-10-408-9406. E-mail: c.vanduijn{at}erasmusmc.nl

Background: The renin-angiotensin system plays an important role in homeostasis and lately, its main effector, angiotensin II, has been attributed with angiogenic and growth factor actions in the breast tissue. Previous studies have shown that the insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme (ACE) gene accounts for the variability of ACE plasma concentrations. The use of ACE inhibitors and the ACE I/D polymorphism may be linked to breast cancer risk. In this study, we evaluate the relationship of the ACE I/D polymorphism with breast cancer risk in Caucasian postmenopausal women.

Methods: The ACE I/D polymorphism was genotyped in 4,117 women participants in the Rotterdam Study. Baseline information was obtained through a questionnaire. We conducted a logistic regression and survival analysis to assess the risk of breast cancer by the ACE genotype.

Results: The DD carriers showed a significantly increased risk of developing breast cancer when compared with the II carriers (odds ratio, 1.86; 95% confidence interval, 1.06-3.27; P = 0.03). This association remained after adjusting for other risk factors, including body mass index, age at menarche, age at menopause, hormone replacement therapy, and hypertension. Our survival analysis showed that the cancer-free survival was significantly reduced in DD compared with II carriers (hazard ratio, 1.80; 95% confidence interval, 1.07-3.01; P = 0.03).

Conclusions: Our results suggest that the ACE I/D polymorphism plays an important role in breast cancer risk and disease-free survival in Caucasian postmenopausal women.

This article has been cited by other articles:

				M. Sugimoto, T. Furuta, N. Shirai, M. Ikuma, H. Sugimura, and A. Hishida Influences of chymase and Angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1929 - 1934. [Abstract] [Full Text] [PDF]